27.05.2019 Views

Swissmedic Annual Report 2018

2018 Annual Report and annual financial statements of the Swiss Agency for Therapeutic Products (Swissmedic)

2018 Annual Report and annual financial statements of the Swiss Agency for Therapeutic Products (Swissmedic)

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

62 Market access | Medical devices<br />

European market surveillance activities<br />

Since Switzerland is integrated into the European medical<br />

devices system, it carries out market surveillance activities in<br />

consultation with partner authorities from contracting<br />

states in addition to its national market surveillance<br />

activities.<br />

Activities<br />

• The number of requests for mutual assistance from<br />

European partner authorities rose from 144 to 180.<br />

• The number of requests made by <strong>Swissmedic</strong> to<br />

European partners remained stable at 32.<br />

• As part of efforts to step up surveillance of CABs and<br />

accredit them under the new European Regulations<br />

(MDR/IVDR), <strong>Swissmedic</strong> once again took part in<br />

internationally accompanied audits of CABs during<br />

<strong>2018</strong>.<br />

Materiovigilance<br />

Activities<br />

• A total of 2,488 incidents were reported in Switzerland,<br />

a further sharp increase of 36 % on the previous year’s<br />

figure.<br />

• The implementation of corrective safety measures in<br />

Switzerland was monitored in 676 cases. A total of 72<br />

reports on defective medical devices (National Competent<br />

Authority <strong>Report</strong>s, NCARs) were prepared for<br />

distribution to foreign authorities, while <strong>Swissmedic</strong><br />

received 845 NCARs from its European partner<br />

authorities.<br />

• In 634 cases, a public safety report was published on<br />

the <strong>Swissmedic</strong> website for the information of users.<br />

• In <strong>2018</strong>, <strong>Swissmedic</strong> again discussed new suspected<br />

incidents and concrete action on pending cases during<br />

monthly telephone conferences with the other European<br />

surveillance authorities.<br />

• With <strong>Swissmedic</strong>’s active participation, the new<br />

Manufacturer’s Incident <strong>Report</strong> (MIR) form was drawn<br />

up, approved and introduced throughout Europe.<br />

Manufacturers and users have an obligation to inform<br />

<strong>Swissmedic</strong> of adverse events that take place in Switzerland.<br />

Companies must also inform <strong>Swissmedic</strong> of measures<br />

they have taken, such as product recalls, which the Agency<br />

then monitors. <strong>Swissmedic</strong> is integrated within the European<br />

reporting system and also informs affected contracting<br />

states about incidents and measures taken in Switzerland.<br />

<strong>2018</strong><br />

72<br />

2017<br />

77<br />

845<br />

870<br />

1850<br />

2488<br />

2987<br />

3650<br />

2016<br />

98<br />

850<br />

1605<br />

2836<br />

Incidents; number of reports from Switzerland<br />

Incidents; number of reports overall:<br />

materiovigilance cases opened<br />

NCARs received<br />

NCARs issued

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!